-
1 . Academic Journal
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
- 저자
- by Lobo, Suzana Margareth; Plantefève, Gaétan; Nair, Girish; Joaquim Cavalcante, Adilson; Franzin de Moraes, Nara, et al.
- 소스
- In eClinicalMedicine February 2024 68